title: Moxifloxacin-associated neutropenia.
abstract: A 32-y-old woman presented with pneumonia. Treatment was started with moxifloxacin. On day 2 of moxifloxacin treatment the patient developed neutropenia. After discontinuing the moxifloxacin, neutrophil counts were normal on day 4. Clinicians should be aware of the possibility of this adverse effect in patients treated with moxifloxacin.
authors.affiliation: Deparment of Medical Oncology, Erciyes University Medical School, Kayseri,Turkey. veliberk@gmail.com
authors.forename: Veli
authors.initials: V
authors.lastname: Berk
authors.forename: Hayati
authors.initials: H
authors.lastname: Demiraslan
authors.forename: Elife
authors.initials: E
authors.lastname: Berk
authors.forename: Halit
authors.initials: H
authors.lastname: Karaca
authors.forename: Mevlude
authors.initials: M
authors.lastname: Inanc
authors.forename: Oktay
authors.initials: O
authors.lastname: Bozkurt
authors.forename: Metin
authors.initials: M
authors.lastname: Ozkan
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001372:Aza Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D007958:Leukocyte Count; D000077266:Moxifloxacin; D009503:Neutropenia / Q000139:chemically induced*; D011014:Pneumonia / Q000097:blood / Q000188:drug therapy; D011804:Quinolines / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin